iGMDRD112
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Methotrexate | CHEMBL3244648 CHEMBL34259 CHEMBL1376974 | 126941 | D02115 | DB00563 | Alone | DNC000933 | Small Molecule |
Drug Class:
Abortifacient AgentsAbortifacient Agents, NonsteroidalAminopterinAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntirheumatic AgentsBCRP/ABCG2 SubstratesBiological FactorsCardiotoxic antineoplastic agentsDermatologicalsEnzyme InhibitorsFolate Analog Metabolic InhibitorFolic Acid AnaloguesFolic Acid AntagonistsHeterocyclic CompoundsHeterocyclic Compounds, 2-RingImmunologic FactorsImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acid Synthesis InhibitorsOAT3 SubstratesOATP1B1/SLCO1B1 SubstratesP-glycoprotein/ABCB1 SubstratesPigments, BiologicalPteridinesPterinsReproductive Control AgentsToxic ActionsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
8266 | UBL4A | 1 |
9757 | KMT2B | 1 |
1387 | CREBBP | 1 |
1111 | CHEK1 | 1 |
4851 | NOTCH1 | 1 |
7158 | TP53BP1 | 1 |
238 | ALK | 1 |
2064 | ERBB2 | 1 |
983 | CDK1 | 1 |
6850 | SYK | 1 |
10413 | YAP1 | 1 |
3932 | LCK | 1 |
7157 | TP53 | 1 |
3673 | ITGA2 | 1 |
3791 | KDR | 1 |
4086 | SMAD1 | 1 |
2309 | FOXO3 | 1 |
4904 | YBX1 | 1 |
4089 | SMAD4 | 1 |
1956 | EGFR | 1 |
3553 | IL1B | 1 |
1977 | EIF4E | 1 |
2648 | KAT2A | 1 |
9223 | MAGI1 | 1 |
5111 | PCNA | 1 |
100862685 | ERVK-19 | 1 |
2065 | ERBB3 | 1 |
54790 | TET2 | 1 |
142 | PARP1 | 1 |
4763 | NF1 | 1 |
Gene in drug-gene network: Network Plot
Models in Methotrexate